Loading...
XSAU
2070
Market cap918mUSD
Nov 12, Last price  
28.88SAR
Name

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

Chart & Performance

D1W1MN
XSAU:2070 chart
P/E
18.69
P/S
2.02
EPS
1.54
Div Yield, %
—
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
1.82%
Revenues
1.71b
+1.47%
727,838,041797,748,000871,939,000950,741,0001,037,640,9801,129,218,0821,244,904,5361,296,623,0731,470,185,8271,705,050,8881,841,194,3471,386,041,5241,274,819,4881,552,515,0781,559,477,0281,459,783,9691,426,337,0881,653,084,0001,682,000,0001,706,700,000
Net income
184m
+651.58%
99,149,729121,864,000128,269,000154,804,000176,524,996211,433,264232,632,902266,820,753316,853,033357,053,878376,691,747197,365,535102,828,944-481,072,349124,787,29526,454,090-170,231,771-13,711,00024,535,000184,400,000
CFO
272m
P
99,670,858120,234,000109,295,000124,450,000135,981,552108,818,580147,583,943157,749,67943,238,950-38,468,7179,408,046155,344,481-80,503,165349,990,8909,735,67986,712,689-124,198,13247,734,000-331,000,000272,353,000
Dividend
Jun 09, 20220.6 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 1986 and headquartered in Buraydah, Saudi Arabia, Saudi Pharmaceutical Industries and Medical Appliances is dedicated to the development, manufacturing, and marketing of medicinal products and pharmaceutical formulations. Its operational footprint spans the Kingdom of Saudi Arabia, Egypt, the broader Middle East, Morocco, and Algeria. The company's extensive portfolio also includes the production of basic chemical substances, human-use medicines (including cosmetics), and the wholesale and retail distribution of pharmaceuticals and related items. Moreover, it actively develops, produces, and sells medical appliances in addition to pharmaceutical products, and undertakes the operation and maintenance of healthcare facilities. A core aspect of its mission is engaging in advanced research and development within medical science.
URL
https://spimaco.com.sa/
IPO date
Jan 01, 1994
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT